Clioquinol and hydrocortisone Topical

Avoid getting this medication in your eyes, mouth, and nose, or on your lips.

Avoid being near people who are sick or have infections. Call your doctor for preventive treatment if you are exposed to chicken pox or measles. These conditions can be serious or even fatal in people who are using clioquinol and hydrocortisone.

Avoid using other medications on the areas you treat with clioquinol and hydrocortisone topical unless your doctor tells you to. Avoid using skin products that can cause irritation, such as harsh soaps, shampoos, or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime.

Clioquinol may stain skin, clothing, and other fabrics it comes in contact with. Take care not to get this medicine on your clothes, carpet, or bed linens.

It is not likely that other drugs you take orally or inject will have an effect on topically applied clioquinol and hydrocortisone. But many drugs can interact with each other. Tell each of your healthcare providers about all medicines you use, including prescription and over-the-counter medicines, vitamins, and herbal products.

Apply a thin layer topically to the affected area(s) 2 to 4 times a day or as directed

Comments: This product has not been found by the US FDA to be safe and effective and the product labeling has not been approved.

Uses: Based on a review of this drug by the National Academy of Sciences-National Research Council and/or other information, FDA has classified the indications as follows:
-Possibly effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; infantile eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); moniliasis; intertrigo

2 years or older: Apply a thin layer topically to the affected area(s) 2 to 4 times a day or as directed

Comments:
-This product has not been found by the US FDA to be safe and effective and the product labeling has not been approved.
-Administration of topical corticosteroids to children should be limited to the lowest effective dose for the shortest duration possible.
-Chronic corticosteroid therapy may interfere with growth and development in pediatric patients.

Uses: Based on a review of this drug by the National Academy of Sciences-National Research Council and/or other information, FDA has classified the indications as follows:
-Possibly effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; infantile eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); moniliasis; intertrigo

Safety and efficacy have not been established in patients younger than 2 years.

Consult WARNINGS section for additional precautions.